HedgeChatter

  • Home /
  • Tag Archives

VSTM

Verastem Supports Worldwide Rare Disease Day on February 28, 2014

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced its support of the rare disease awareness events being held globally. moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here […]

February 28, 2014 Bystocknews , Comments Off on Verastem Supports Worldwide Rare Disease Day on February 28, 2014 read more

Verastem to Present at Upcoming Scientific Conferences

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will present at two upcoming scientific conferences, including the 12th International moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring […]

February 26, 2014 Bystocknews , Comments Off on Verastem to Present at Upcoming Scientific Conferences read more

7:05 am Verastem acquires rights to cancer stem cell inhibitor VS-4718; acquisition reduces milestones and royalties associated with ongoing VS-4718 development

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

February 25, 2014 Bystocknews , Comments Off on 7:05 am Verastem acquires rights to cancer stem cell inhibitor VS-4718; acquisition reduces milestones and royalties associated with ongoing VS-4718 development read more

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard Pharmaceuticals. moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, […]

February 25, 2014 Bystocknews , Comments Off on Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718 read more

4:05 pm Verastem announces that a publication in the journal Cancer Research supports the scientific rationale for the co’s ongoing development program of targeting cancer stem cells in mesothelioma

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

February 25, 2014 Bystocknews , Comments Off on 4:05 pm Verastem announces that a publication in the journal Cancer Research supports the scientific rationale for the co’s ongoing development program of targeting cancer stem cells in mesothelioma read more

4:05 pm Verastem announces that a publication in the journal Cancer Research supports the scientific rationale for the co’s ongoing development program of targeting cancer stem cells in mesothelioma

moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is hiring next, click here to view […]

February 24, 2014 Bystocknews , Comments Off on 4:05 pm Verastem announces that a publication in the journal Cancer Research supports the scientific rationale for the co’s ongoing development program of targeting cancer stem cells in mesothelioma read more

Cancer Research Publication Highlights Importance of Merlin Loss and Cancer Stem Cells in Mesothelioma

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that a publication in the journal Cancer Research supports the scientific rationale for the Compa moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is […]

February 24, 2014 Bystocknews , Comments Off on Cancer Research Publication Highlights Importance of Merlin Loss and Cancer Stem Cells in Mesothelioma read more

Verastem to Host Conference Call on March 6th to Discuss Year-End 2013 Financial Results and Recent Highlights

[Business Wire] – Verastem, Inc. , focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that the Company will host a conference call on Thursday, March 6, 2014 at 8:00 a.m. moreView todays social media effects on VSTMView the latest stocks trending across Twitter. Click to view dashboardSee who Verastem is […]

February 19, 2014 Bystocknews , Comments Off on Verastem to Host Conference Call on March 6th to Discuss Year-End 2013 Financial Results and Recent Highlights read more